Chemed downgraded to Hold from Buy at Jefferies

Jefferies analyst Brian Tanquilut downgraded Chemed (CHE) to Hold from Buy with a price target of $475, down from $550. The firm is “incrementally negative” on the company’s Roto Rooter business given persistent margin headwinds, limited visibility into improvement, and its view that a path to normalized growth in 2026 appears unlikely. As such, Jefferies expects Chemed shares to trade sideways absent a strategic announcement.